Is the Compulsory Licensing Mechanism Guaranteed by TRIPS the Best Remedy to Improve Access to Biological Therapies Worldwide?. Eastern European Journal of Transnational Relations, Bialystok, PL, v. 3, n. 1, p. 39–52, 2019. DOI: 10.15290/eejtr.2019.03.01.03. Disponível em: https://eejtr.uwb.edu.pl/article/view/34.. Acesso em: 3 nov. 2024.